SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...
The need for continuous renal replacement therapy may be associated with high risk of mortality among adult patients with acetaminophen-induced acute liver failure. Patients with acute liver failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results